Literature DB >> 8405810

Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation.

I Mononen1, K J Fisher, V Kaartinen, N N Aronson.   

Abstract

Aspartylglycosaminuria (AGU) (McKusick 20840) is the most common disorder of glycoprotein degradation caused by the failure of lysosomes to digest the protein-to-carbohydrate linkage of Asn-linked glycoproteins. During the past few years there has been significant progress in our understanding of both the protein chemistry and molecular biology of glycosylasparaginase (EC 3.5.1.26) as well as the molecular changes underlying the storage disease AGU that results from deficiency of this lysosomal hydrolase. Modern clinical assays have been developed for the diagnosis and carrier detection of this disease. Detailed structure, substrate specificity, mechanism of action, and a part of the active site of glycosylasparaginase have been defined. Molecular biology of glycosylasparaginase has progressed rapidly and already some mutations in the glycosylasparaginase gene resulting in AGU have been identified. Evolutionary aspects based on sequence data indicate a mechanistic relationship between mammalian glycosylasparaginases and bacterial/plant asparaginases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405810     DOI: 10.1096/fasebj.7.13.8405810

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

1.  Searching databases of conserved sequence regions by aligning protein multiple-alignments.

Authors:  S Pietrokovski
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

2.  Crystal structure of glycosylasparaginase from Flavobacterium meningosepticum.

Authors:  J Xuan; A L Tarentino; B G Grimwood; T H Plummer; T Cui; C Guan; P Van Roey
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

3.  Susceptibility-Weighted Imaging Findings in Aspartylglucosaminuria.

Authors:  A Tokola; M Laine; R Tikkanen; T Autti
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

4.  Structural basis of a point mutation that causes the genetic disease aspartylglucosaminuria.

Authors:  Lufei Sui; Damodharan Lakshminarasimhan; Suchita Pande; Hwai-Chen Guo
Journal:  Structure       Date:  2014-11-13       Impact factor: 5.006

5.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

Authors:  J C Skipper; R C Hendrickson; P H Gulden; V Brichard; A Van Pel; Y Chen; J Shabanowitz; T Wolfel; C L Slingluff; T Boon; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

6.  Phenotypic characterization of mice with targeted disruption of glycosylasparaginase gene: a mouse model for aspartylglycosaminuria.

Authors:  V Kaartinen; I Mononen; I Gonzalez-Gomez; T Noronkoski; N Heisterkamp; J Groffen
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

7.  Single base deletion in exon 7 of the glycosylasparaginase gene causes a mild form of aspartylglycosaminuria in a patient of Mauritian origin.

Authors:  H Park; M Rossiter; A H Fensom; B Winchester; N N Aronson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Progressive neurodegeneration in aspartylglycosaminuria mice.

Authors:  I Gonzalez-Gomez; I Mononen; N Heisterkamp; J Groffen; V Kaartinen
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  Investigating the interaction of saposin C with POPS and POPC phospholipids: a solid-state NMR spectroscopic study.

Authors:  Shadi Abu-Baker; Xiaoyang Qi; Gary A Lorigan
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

10.  Structures of apo and product-bound human L-asparaginase: insights into the mechanism of autoproteolysis and substrate hydrolysis.

Authors:  Julian Nomme; Ying Su; Manfred Konrad; Arnon Lavie
Journal:  Biochemistry       Date:  2012-08-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.